Stifel Financial’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Stifel Financial's ADPT Position: Q2 2026 in Review
Stifel Financial opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 15,924 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #3219 among its holdings. This is a return to the name: Stifel Financial previously reported a position in ADPT as recently as Q3 2025.
Stifel Financial first reported a position in ADPT in Q2 2022 and has held it in 4 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Stifel Financial held 15,924 shares of Adaptive Biotechnologies worth $342K as of Q2 2026.
- Adaptive Biotechnologies was a new Stifel Financial position in Q2 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3219 holding.
- Stifel Financial first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 4 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.